• Something wrong with this record ?

Rare alleles within the CYP2E1 (MEOS system) could be associated with better short-term health outcome after acute methanol poisoning

JA. Hubacek, D. Pelclova, Z. Seidl, M. Vaneckova, J. Klempir, E. Ruzicka, P. Ridzon, P. Urban, Z. Fenclova, V. Petrik, P. Diblik, P. Kuthan, M. Miovsky, B. Janikova, V. Adamkova, S. Zakharov,

. 2015 ; 116 (2) : 168-72. [pub] 20140919

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc15031897

Genetic polymorphisms influence the metabolism of ethanol and methanol, but the potential effects of genetic predisposition on the clinical course, outcome and short-term health sequelae of acute methanol poisoning are unknown. To evaluate the role of the MEOS system in methanol poisoning, we analysed the effect of three polymorphisms (RsaI - rs2031920; PstI - rs3813867; insertion/deletion I/D) within the CYP2E1 enzyme (MEOS system) in 50 adult survivors of methanol poisoning and compared their genotype frequencies with 460 controls. The minor allele frequencies of all three polymorphisms were below 5% in both groups. We did not detect significant differences in the genotype frequencies between survivors of methanol poisoning and controls (p = 0.34 for the RsaI variant; p = 0.59 for the PstI variant and p = 0.21 for the I/D polymorphism). The carriers of at least one minor allele in the CYP2E1 gene had less severe clinical symptoms and better short-term outcome after acute poisoning. Variants within the CYP2E1 gene are likely not significant genetic determinants of acute methanol poisoning (if survivors are analysed), but they may influence the severity of methanol poisoning and its visual/central nervous system (CNS) outcome.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15031897
003      
CZ-PrNML
005      
20250403085423.0
007      
ta
008      
151005s2015 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/bcpt.12310 $2 doi
035    __
$a (PubMed)25146350
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Hubacek, Jaroslav A $u Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
245    10
$a Rare alleles within the CYP2E1 (MEOS system) could be associated with better short-term health outcome after acute methanol poisoning / $c JA. Hubacek, D. Pelclova, Z. Seidl, M. Vaneckova, J. Klempir, E. Ruzicka, P. Ridzon, P. Urban, Z. Fenclova, V. Petrik, P. Diblik, P. Kuthan, M. Miovsky, B. Janikova, V. Adamkova, S. Zakharov,
520    9_
$a Genetic polymorphisms influence the metabolism of ethanol and methanol, but the potential effects of genetic predisposition on the clinical course, outcome and short-term health sequelae of acute methanol poisoning are unknown. To evaluate the role of the MEOS system in methanol poisoning, we analysed the effect of three polymorphisms (RsaI - rs2031920; PstI - rs3813867; insertion/deletion I/D) within the CYP2E1 enzyme (MEOS system) in 50 adult survivors of methanol poisoning and compared their genotype frequencies with 460 controls. The minor allele frequencies of all three polymorphisms were below 5% in both groups. We did not detect significant differences in the genotype frequencies between survivors of methanol poisoning and controls (p = 0.34 for the RsaI variant; p = 0.59 for the PstI variant and p = 0.21 for the I/D polymorphism). The carriers of at least one minor allele in the CYP2E1 gene had less severe clinical symptoms and better short-term outcome after acute poisoning. Variants within the CYP2E1 gene are likely not significant genetic determinants of acute methanol poisoning (if survivors are analysed), but they may influence the severity of methanol poisoning and its visual/central nervous system (CNS) outcome.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a alely $7 D000483
650    _2
$a cytochrom P-450 CYP2E1 $x genetika $7 D019392
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a frekvence genu $7 D005787
650    _2
$a genetická predispozice k nemoci $7 D020022
650    _2
$a genotyp $7 D005838
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a methanol $x otrava $7 D000432
650    _2
$a lidé středního věku $7 D008875
650    12
$a polymorfismus genetický $7 D011110
650    _2
$a stupeň závažnosti nemoci $7 D012720
650    _2
$a přežívající $7 D017741
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Pelclova, Daniela
700    1_
$a Seidl, Zdenek
700    1_
$a Vaneckova, Manuela
700    1_
$a Klempir, Jiri
700    1_
$a Ruzicka, Evzen
700    1_
$a Ridzon, Petr
700    1_
$a Urban, Pavel
700    1_
$a Fenclová, Zdeňka, $d 1958- $7 xx0074215
700    1_
$a Petrik, Vit
700    1_
$a Diblik, Pavel
700    1_
$a Kuthan, Pavel
700    1_
$a Miovsky, Michal
700    1_
$a Janikova, Barbara
700    1_
$a Adamkova, Vera $7 gn_A_00001463
700    1_
$a Zakharov, Sergey
773    0_
$w MED00007578 $t Basic & clinical pharmacology & toxicology $x 1742-7843 $g Roč. 116, č. 2 (2015), s. 168-72
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25146350 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20151005 $b ABA008
991    __
$a 20250403085418 $b ABA008
999    __
$a ok $b bmc $g 1092773 $s 915023
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 116 $c 2 $d 168-72 $e 20140919 $i 1742-7843 $m Basic & clinical pharmacology & toxicology $n Basic Clin Pharmacol Toxicol $x MED00007578
LZP    __
$a Pubmed-20151005

Find record

Citation metrics

Archiving options